![Amer Zeidan: Meeting 1st mentor Peter Kouides every The American Society of Hematology (ASH) is a tradition I cherish](https://oncodaily.com/pub/uploads/2023/12/GBet89tWYAAqhJz.png)
Amer Zeidan: Meeting 1st mentor Peter Kouides every The American Society of Hematology (ASH) is a tradition I cherish
Amer Zeidan shared on X/Twitter:
“Meeting 1st mentor Peter Kouides every The American Society of Hematology (ASH) is a tradition I cherish. Peter helped me to start in research. I continued with 2nd mentor Dr Meir Wezler, RIP, focusing on AMLsm. At Johns Hopkins University came 3rd mentor Steve Gore (also saw in ASH23) where my MDSsm story started”
Source: Amer Zeidan/X
Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center.
Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023